Retatrutide vs Liraglutide
Which has more real evidence behind it? This compares how well each has been tested, not which one works better.
This page has not yet been reviewed by a credentialed medical professional. It is educational and is not medical advice.
Liraglutide has the stronger evidence: FDA-approved, compared with human trials for Retatrutide.
The research, side by side
Counts come from PubMed and ClinicalTrials.gov searches and can include studies that only mention a peptide. Bars use a log scale.
| Retatrutide | Liraglutide | |
|---|---|---|
| What people use it for | Weight loss and type 2 diabetes. A triple GIP/GLP-1/glucagon agonist with positive phase 3 results that is not approved yet, but is widely sold online anyway. | Weight loss (Saxenda) and type 2 diabetes (Victoza). A daily GLP-1 drug that came before semaglutide. |
| Approved as a medicine | No | Type 2 diabetes; chronic weight management |
| What the evidence says | Phase 2 and phase 3 clinical trials demonstrate up to 24% weight loss in adults with obesity and significant HbA1c reductions in type 2 diabetes. Unapproved; Lilly plans FDA submission in 2027. | Approved, with large randomized trials. Semaglutide beat it head-to-head for weight loss. |
| In tested sport | Check the WADA list | Not prohibited |
Common questions
Which is better, Retatrutide or Liraglutide?
No study compares them head to head for most uses, so this page compares how much evidence exists, not which works better. Liraglutide has the stronger evidence: FDA-approved, compared with human trials for Retatrutide.
Is Retatrutide or Liraglutide approved?
Retatrutide: not an approved medicine. Liraglutide: Type 2 diabetes; chronic weight management.
Can you take Retatrutide and Liraglutide together?
We found no controlled studies testing Retatrutide and Liraglutide together, so the effects and safety of combining them are unknown. Talk to a clinician.
Keep exploring
Educational only, not medical advice. "What people use it for" describes common claims, not recommendations.